Cara Therapeutics
3 followers
‌
Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs.
Industries
Headquarters
Employees
Links
Org chart
Christopher Posner
CEO, President & Director
Christopher Posner
Collapse
Ryan Maynard
Chief Financial Officer
Frédérique Menzaghi
Chief Scientific Officer, SVP Research & Development
Jo Goncalves
Chief Medical Officer
Scott Terrillion
General Counsel, Secretary & Chief Compliance Officer
Eric Vandal
SVP, Commercial
Beth Weinberg
SVP, Regulatory Affairs & QA
Stephen O’Connor
Vice President CMC Technical Operations
Similar companies
REVOLUTION Medicines
5 followers
Halozyme Therapeutics
4 followers
Stemline Therapeutics
3 followers
Celularity
3 followers
Atomwise
3 followers
Pivot Bio
2 followers
Quantum-Si
2 followers
Arbutus Biopharma
2 followers
Keros Therapeutics
1 follower
Vividion Therapeutics
1 follower
Century Therapeutics
1 follower
Discover companies